MedKoo Cat#: 573181 | Name: Lincomycin hydrochloride anhydrous
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Lincomycin hydrochloride anhydrous is an antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.

Chemical Structure

Lincomycin hydrochloride anhydrous
Lincomycin hydrochloride anhydrous
CAS#859-18-7 (HCl)

Theoretical Analysis

MedKoo Cat#: 573181

Name: Lincomycin hydrochloride anhydrous

CAS#: 859-18-7 (HCl)

Chemical Formula: C18H35ClN2O6S

Exact Mass: 442.1904

Molecular Weight: 444.00

Elemental Analysis: C, 48.80; H, 7.96; Cl, 8.00; N, 6.32; O, 21.67; S, 7.24

Price and Availability

Size Price Availability Quantity
1g USD 350.00 2 Weeks
5g USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Antibiotic 124a HCl, Lincomycin HCl, Lincomycin hydrochloride anhydrous, Mycivin
IUPAC/Chemical Name
(2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
InChi Key
POUMFISTNHIPTI-BOMBIWCESA-N
InChi Code
1S/C18H34N2O6S.ClH/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4;/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25);1H/t9-,10-,11+,12-,13+,14-,15-,16-,18-;/m1./s1
SMILES Code
CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O.Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Product Data
Biological target:
Lincomycin Hydrochloride(U10149A) is an antibiotic produced by Streptomyces lincolnensis var.
In vitro activity:
Treatment with LM (lincomycin) or LM + DX (dexamethasone) stimulated proliferation of melanoma cells with minimal cytotoxicity, while DX did not influence cell proliferation either alone or in combination with LM. Treatment with LM alone increased tyrosinase activity slightly and reduced melanin content in a dose-dependent manner. However, LM counteracted the pronounced increase in tyrosinase elicited by DX and also abrogated the dose-dependent increase in melanin content elicited by DX. Reference: Pigment Cell Res. 1998 Jun;11(3):143-50. https://pubmed.ncbi.nlm.nih.gov/9730321/
In vivo activity:
Lincomycin (LCM), imipenem (IPM), cilastatine (CS), and ampicillin (ABPC) were used for antibiotics treatment. The survival rate of SPG/IND-treated mice was significantly increased by administering LCM or ABPC/IPM/CS, and the effect was more significant by LCM. Reference: Biol Pharm Bull. 2007 Dec;30(12):2312-6. https://pubmed.ncbi.nlm.nih.gov/18057718/
Solvent mg/mL mM comments
Solubility
DMSO 89.0 200.45
Water 89.0 200.45
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 444.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Nameda S, Miura NN, Adachi Y, Ohno N. Lincomycin protects mice from septic shock in beta-glucan-indomethacin model. Biol Pharm Bull. 2007 Dec;30(12):2312-6. doi: 10.1248/bpb.30.2312. PMID: 18057718. 2. Kim DG, Kim HY, Kim MY, Lee MY, You KR. Lincomycin abrogates dexamethasone-enhanced melanogenesis in B16 melanoma cells. Pigment Cell Res. 1998 Jun;11(3):143-50. doi: 10.1111/j.1600-0749.1998.tb00724.x. PMID: 9730321.
In vitro protocol:
1. Nameda S, Miura NN, Adachi Y, Ohno N. Lincomycin protects mice from septic shock in beta-glucan-indomethacin model. Biol Pharm Bull. 2007 Dec;30(12):2312-6. doi: 10.1248/bpb.30.2312. PMID: 18057718. 2. Kim DG, Kim HY, Kim MY, Lee MY, You KR. Lincomycin abrogates dexamethasone-enhanced melanogenesis in B16 melanoma cells. Pigment Cell Res. 1998 Jun;11(3):143-50. doi: 10.1111/j.1600-0749.1998.tb00724.x. PMID: 9730321.
In vivo protocol:
1. Nameda S, Miura NN, Adachi Y, Ohno N. Lincomycin protects mice from septic shock in beta-glucan-indomethacin model. Biol Pharm Bull. 2007 Dec;30(12):2312-6. doi: 10.1248/bpb.30.2312. PMID: 18057718.
1: Chen CE, Zhang H, Ying GG, Zhou LJ, Jones KC. Passive sampling: A cost-effective method for understanding antibiotic fate, behaviour and impact. Environ Int. 2015 Dec;85:284-91. doi: 10.1016/j.envint.2015.10.001. Epub 2015 Oct 30. PubMed PMID: 26451705.